Published in Histopathology on October 01, 2005
Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma. J Clin Microbiol (2009) 0.96
EBV-associated colitis mimicking IBD in an immunocompetent individual. Nat Rev Gastroenterol Hepatol (2010) 0.85
Ulcerative gastritis secondary to Epstein-Barr viral infection. Dig Dis Sci (2009) 0.77
A Case Report of NK-Cell Lymphoproliferative Disease With a Wide Involvement of Digestive Tract Develop Into Epstein-Barr Virus Associated NK/T Cell Lymphoma in an Immunocompetent Patient. Medicine (Baltimore) (2016) 0.75
Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report. Int J Clin Exp Pathol (2015) 0.75
[Nonbacterial colitides]. Pathologe (2011) 0.75
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell (1995) 3.17
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34
Host genetic factors influence disease progression in chronic hepatitis C. Hepatology (2000) 2.26
Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation (1990) 2.13
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12
Rectal biopsy in patients presenting to an infectious disease unit with diarrhoeal disease. Gut (1979) 2.12
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol (1989) 2.10
Humour experience in schizophrenia: relationship with executive dysfunction and psychosocial impairment. Psychol Med (2008) 1.99
Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet (2001) 1.89
The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively--a randomised clinical trial. Clin Nutr (2005) 1.88
Liver resection and transplantation in the management of iatrogenic biliary injury. World J Surg (2007) 1.83
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg (2006) 1.69
Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int J Cancer (1979) 1.62
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Open cholecystectomy in the laparoscopic era. Br J Surg (2007) 1.56
Renal dysfunction in obstructive jaundice. Br J Surg (1995) 1.53
Does a history of cardiac disease or hypertension increase mortality following primary elective total hip arthroplasty? Surgeon (2007) 1.49
Total knee replacement in morbidly obese patients. Results of a prospective, matched study. J Bone Joint Surg Br (2006) 1.49
Risk assessment in acute pancreatitis. Br J Surg (2009) 1.47
Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology (2003) 1.47
Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes. Nucleic Acids Res (1986) 1.45
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. Hepatology (2000) 1.45
EB virus induction is associated with B-cell maturation. Immunology (1986) 1.45
What proportion of basic surgical trainees continue in a surgical career? A survey of the factors which are important in influencing career decisions. Surgeon (2009) 1.43
Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br J Surg (2010) 1.39
Helicobacter pylori and non-ulcer dyspepsia in Zambia. Trop Doct (1992) 1.38
Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry (1998) 1.37
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis. Int J Cancer (1974) 1.37
Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv Cancer Res (1991) 1.36
Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology (1998) 1.35
Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet (1991) 1.35
DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J (1995) 1.33
Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J Gen Virol (1993) 1.33
Arteriovenous malformations of the intestine. Surg Gynecol Obstet (1979) 1.30
Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol (1998) 1.28
Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol (2003) 1.28
Dermatitis herpetiformis: diagnosis, diet and demography. Gut (1984) 1.28
Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines. Mol Biol Med (1984) 1.27
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) (2007) 1.26
Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet (1988) 1.25
Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J (1995) 1.23
Vulval tuberculosis. Tubercle (1979) 1.22
Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon (2003) 1.20
Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer (2003) 1.19
High flow oxygen therapy for pneumatosis coli. Gut (1979) 1.18
Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen. Nucleic Acids Res (1988) 1.18
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol (2001) 1.17
B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain (2003) 1.16
Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol (1997) 1.16
Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology (1988) 1.16
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Diffuse neurofibroma of the ankle. Clin Radiol (1998) 1.15
Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol (2000) 1.13
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus. Transplantation (2000) 1.12
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
Interstitial ablative techniques for hepatic tumours. Br J Surg (2003) 1.10
Lymphocytes activated by the Epstein-Barr virus to produce immunoglobulin do not express CD23 or become immortalized. Int J Cancer (1988) 1.10
Infection with E.B. virus and rheumatoid arthritis. Lancet (1979) 1.10
Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol (1997) 1.09
Early specialist repair of biliary injury. Br J Surg (2006) 1.09
Production of human monoclonal antibody to rhesus D antigen. Lancet (1983) 1.09
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy. J Gastroenterol Hepatol (1999) 1.08
Clinical spectrum of "solitary ulcer" of the rectum. Gastroenterology (1983) 1.08
An audit of the management of patients with acute pancreatitis against national standards of practice. Br J Surg (2007) 1.05
The ins and outs of EBV infection. Trends Microbiol (2000) 1.05
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl (2000) 1.04
Pre-operative high sensitivity C-reactive protein and postoperative outcome in patients undergoing elective orthopaedic surgery. Anaesthesia (2007) 1.03
Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. J Hepatol (1999) 1.03
Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl (2003) 1.03
The role of EBV in post-transplant malignancies: a review. J Clin Pathol (2000) 1.02
Cholangiocarcinoma arising after biliary-enteric drainage procedures for benign disease. Gut (2002) 1.01
Hepatic resection for benign non-cystic liver lesions. HPB (Oxford) (2004) 1.01
Proctitis in homosexual men. A diagnostic problem. Br J Vener Dis (1983) 0.99
Epstein-Barr (EB) virus infection in homosexual men in London. Br J Vener Dis (1984) 0.98
Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol (1999) 0.97
A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation (1997) 0.97
Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients. Int J Cancer (1981) 0.96
Prednisolone in giant hypertrophic gastritis (Menetrier's disease). Am J Dig Dis (1976) 0.96
Seroepidemiological study of Epstein-Barr virus infection in Bangladesh. J Med Virol (1996) 0.96
Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Virol (1996) 0.96
Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am J Pathol (1991) 0.95
Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis. Hepatology (1997) 0.95
The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol (2004) 0.95
Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Int J Cancer (1989) 0.94
A population-based study of pancreatic trauma in Scotland. World J Surg (2006) 0.94
Antibacterial-induced hepatotoxicity. Incidence, prevention and management. Drug Saf (1996) 0.94
Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. J Gen Virol (1978) 0.94
In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev Med Virol (2000) 0.94
Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. J Med Virol (2009) 0.93
Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension. Gastroenterology (1996) 0.93
Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype. Blood (1993) 0.92